Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5197509
Max Phase: Preclinical
Molecular Formula: C26H28N5O17P3
Molecular Weight: 775.45
Associated Items:
ID: ALA5197509
Max Phase: Preclinical
Molecular Formula: C26H28N5O17P3
Molecular Weight: 775.45
Associated Items:
Canonical SMILES: COc1ccc(C(=O)O[C@@H]2[C@H](OC(=O)c3ccc(OC)cc3)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]2n2cnc3c(N)ncnc32)cc1
Standard InChI: InChI=1S/C26H28N5O17P3/c1-41-16-7-3-14(4-8-16)25(32)45-20-18(11-43-50(37,38)48-51(39,40)47-49(34,35)36)44-24(31-13-30-19-22(27)28-12-29-23(19)31)21(20)46-26(33)15-5-9-17(42-2)10-6-15/h3-10,12-13,18,20-21,24H,11H2,1-2H3,(H,37,38)(H,39,40)(H2,27,28,29)(H2,34,35,36)/t18-,20-,21-,24-/m1/s1
Standard InChI Key: RKFOOQRRMNOARS-UMCMBGNQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 775.45 | Molecular Weight (Monoisotopic): 775.0693 | AlogP: 2.12 | #Rotatable Bonds: 14 |
Polar Surface Area: 309.73 | Molecular Species: ACID | HBA: 18 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 22 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: 4.92 | CX LogP: -0.68 | CX LogD: -5.79 |
Aromatic Rings: 4 | Heavy Atoms: 51 | QED Weighted: 0.09 | Np Likeness Score: 0.75 |
1. Isaak A, Dobelmann C, Füsser FT, Erlitz KS, Koch O, Junker A.. (2022) Unveiling the Structure-Activity Relationships at the Orthosteric Binding Site of P2X Ion Channels: The Route to Selectivity., 65 (16.0): [PMID:35930402] [10.1021/acs.jmedchem.2c00812] |
Source(1):